| Date Filed | Type | Description |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/12/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/11/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 10/10/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 10/06/2023 |
SC 13G
| JANUS HENDERSON GROUP PLC reports a 10.1% stake in SOLENO THERAPEUTICS, INC. |
| 10/05/2023 |
SC 13G
| RA CAPITAL MANAGEMENT, L.P. reports a 4.6% stake in SOLENO THERAPEUTICS, INC. |
| 10/04/2023 |
4
| Vivo Opportunity, LLC (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Exercised (in-or-at-the-money) 5,215,000 options to buy
@ $2.5, valued at
$13M
|
|
| 10/04/2023 |
D
| Form D - Notice of Exempt Offering of Securities: |
| 10/03/2023 |
SC 13D/A
| Carlyle Group Inc. reports a 10% stake in Soleno Therapeutics, Inc. |
| 10/02/2023 |
4
| Carlyle Group Inc. (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Converted 329,930 shares
@ $1.75, valued at
$577.4k
Converted 1,092,056 options to buy
@ $1.75, valued at
$1.9M
Converted 762,126 options to buy
@ $0.01, valued at
$7.6k
|
|
| 09/29/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 09/28/2023 |
SC 13D/A
| PERCEPTIVE ADVISORS LLC reports a 23.7% stake in Soleno Therapeutics, Inc. |
| 09/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/28/2023 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Bought 5,703 shares
@ $7.65, valued at
$43.6k
Bought 13,687 shares
@ $8.3, valued at
$113.6k
Bought 5,419 shares
@ $9.52, valued at
$51.6k
Bought 37,911 shares
@ $11.05, valued at
$418.9k
Bought 77,837 shares
@ $11.81, valued at
$919.3k
Bought 42,838 shares
@ $12.84, valued at
$550k
Bought 30,511 shares
@ $13.92, valued at
$424.7k
Bought 3,326 shares
@ $14.61, valued at
$48.6k
Bought 27,769 shares
@ $16, valued at
$444.3k
Bought 75,477 shares
@ $17.28, valued at
$1.3M
Bought 52,691 shares
@ $18.24, valued at
$961.1k
|
|
| 09/28/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 09/28/2023 |
FWP
| Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses: |
| 09/27/2023 |
S-3MEF
| Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]: |
| 09/27/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
| 09/27/2023 |
8-K
| Termination of a Material Definitive Agreement, Other Events Interactive Data |
| 08/18/2023 |
SC 13D/A
| Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] |
| 08/16/2023 |
4
| Pauls Matthew (Director) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Granted 15,000 options to buy
@ $4.6, valued at
$69k
|
|
| 08/16/2023 |
3
| Pauls Matthew (Director) has filed a Form 3 on SOLENO THERAPEUTICS INC |
| 08/16/2023 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/15/2023 |
SC 13D/A
| PERCEPTIVE ADVISORS LLC reports a 22.1% stake in Soleno Therapeutics, Inc. |
| 08/08/2023 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 08/08/2023 |
8-K
| Quarterly results |
| 08/03/2023 |
EFFECT
| Form EFFECT - Notice of Effectiveness: |
| 07/28/2023 |
S-1/A
| Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] |
| 07/21/2023 |
S-1
| Form S-1 - General form for registration of securities under the Securities Act of 1933: |
| 07/10/2023 |
8-K
| Investor presentation |
| 06/06/2023 |
SC 13D/A
| PERCEPTIVE ADVISORS LLC reports a 27% stake in Soleno Thereputics, Inc. |
| 06/06/2023 |
4
| PERCEPTIVE ADVISORS LLC (10% Owner) has filed a Form 4 on SOLENO THERAPEUTICS INC|
Txns:
| Bought 64,630 shares
@ $5.93, valued at
$383.3k
Bought 78,468 shares
@ $5.98, valued at
$469.2k
Bought 200 shares
@ $5.93, valued at
$1.2k
|
|
| 06/02/2023 |
424B5
| Form 424B5 - Prospectus [Rule 424(b)(5)]: |
|